This document discusses how data sharing is changing healthcare by empowering patients. It outlines a shift from a traditional care model, where patients are passive recipients of care, to one where patients are engaged and empowered through access to their own health data and contextual knowledge. Key drivers of this change include affordable technology, the quantified self-movement, big data, and empowered patients. The document discusses how patient registries and personalized medicine can utilize data to better understand treatment efficacy for similar patients and provide personalized care plans. It also notes challenges around data privacy and the need for guidelines. Overall, the document advocates for empowering patients through access to their own health data while using data and technology to coordinate and improve healthcare.
A brief presentation outlining the concepts of data quality in the context of clinical data, and highlighting the importance of data quality for population health, health analytics, and other secondary uses of clinical data.
Evidence Based Clinical Decision Support – An Enabler for Clinicians in 21st Century by Dr. Lalit Singh, Director for Content & Product Strategy, Elsevier, India
Researchers and care providers wanted to have access to all of the patients` vitals signs (temperature, blood pressure, heart rate, and respiratory rate) but most of this data wasn?t recorded, only a few readings a day were posted to the patients Electronic Medical Record (EMR). The EMR isn`t meant to store such volume of data, let alone to perform any data mining on it. This session will describe the architecture of the solution that was implemented to collect these vital signs automatically from Bedside Medical Devices (BDMI), and store them into a temporary storage, then load them into a Hadoop cluster. The session will also cover how the team married this vital signs data in the HDFS (Hadoop File System) with the rest of the EMR data for our Principles Investigators (PI) in our research institute to search for correlations between administered medications, diagnosis, and vital signs readings. The session will describe the reasons behind the design decisions that were made, such as using a Cloud Hadoop cluster versus on-premises while maintaining HIPAA.
A brief presentation outlining the concepts of data quality in the context of clinical data, and highlighting the importance of data quality for population health, health analytics, and other secondary uses of clinical data.
Evidence Based Clinical Decision Support – An Enabler for Clinicians in 21st Century by Dr. Lalit Singh, Director for Content & Product Strategy, Elsevier, India
Researchers and care providers wanted to have access to all of the patients` vitals signs (temperature, blood pressure, heart rate, and respiratory rate) but most of this data wasn?t recorded, only a few readings a day were posted to the patients Electronic Medical Record (EMR). The EMR isn`t meant to store such volume of data, let alone to perform any data mining on it. This session will describe the architecture of the solution that was implemented to collect these vital signs automatically from Bedside Medical Devices (BDMI), and store them into a temporary storage, then load them into a Hadoop cluster. The session will also cover how the team married this vital signs data in the HDFS (Hadoop File System) with the rest of the EMR data for our Principles Investigators (PI) in our research institute to search for correlations between administered medications, diagnosis, and vital signs readings. The session will describe the reasons behind the design decisions that were made, such as using a Cloud Hadoop cluster versus on-premises while maintaining HIPAA.
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
> HTA and Real World Evidence (RWE)
> Why RWE? - Limitations with RCT
> RCT v/s RWE
> Definition of RWE
> Sources of RWE
> Advantages of RWE
> Application of Real World Data (RWD) in RWE
> Benefits of RWD in RWE
> Why Data Sharing is Important?
> Important Stakeholders
> How to Encourage Data Sharing?
> Benefits of Data Sharing
> Case Studies
> Data Privacy Scenario
> Data Security in India
> Regulatory Perspectives Around RWD/RWE
> Way Forward
The Internet of Things (IoT) is the latest buzzword out of the interface between information technology and business. As technologies like Bluetooth and sensors enable connections between devices and networks, innovation has brought connections between devices and a human interface. In healthcare, this has been termed the Internet of Medical Things or Healthy things. Medical devices and consumer health devices generate data which can be analyzed, synthesized and displayed for the consumer and healthcare provider to get a broader picture of one’s health. Everything from fitness devices to glucose monitors can give us information about our current health status as never before. How this will integrate into a clinician’s workflow is a new journey of discovery as medical practice catches up with these innovations.
In this full-day tutorial, you will learn basic overview of electronic medical records systems, health data management and how you can use the OpenMRS system for data and information management. We will cover basics of installation, user management, location management, patient dashboards and some interesting features that are provided by different modules. You can see how OpenMRS can be customized with different modules that are suitable for different contexts. This tutorial is helpful for new users and developers who would like to know the features of OpenMRS. Individuals who would like to evaluate and try to see if OpenMRS fits their healthcare needs will also benefit from this tutorial.
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
> HTA and Real World Evidence (RWE)
> Why RWE? - Limitations with RCT
> RCT v/s RWE
> Definition of RWE
> Sources of RWE
> Advantages of RWE
> Application of Real World Data (RWD) in RWE
> Benefits of RWD in RWE
> Why Data Sharing is Important?
> Important Stakeholders
> How to Encourage Data Sharing?
> Benefits of Data Sharing
> Case Studies
> Data Privacy Scenario
> Data Security in India
> Regulatory Perspectives Around RWD/RWE
> Way Forward
The Internet of Things (IoT) is the latest buzzword out of the interface between information technology and business. As technologies like Bluetooth and sensors enable connections between devices and networks, innovation has brought connections between devices and a human interface. In healthcare, this has been termed the Internet of Medical Things or Healthy things. Medical devices and consumer health devices generate data which can be analyzed, synthesized and displayed for the consumer and healthcare provider to get a broader picture of one’s health. Everything from fitness devices to glucose monitors can give us information about our current health status as never before. How this will integrate into a clinician’s workflow is a new journey of discovery as medical practice catches up with these innovations.
In this full-day tutorial, you will learn basic overview of electronic medical records systems, health data management and how you can use the OpenMRS system for data and information management. We will cover basics of installation, user management, location management, patient dashboards and some interesting features that are provided by different modules. You can see how OpenMRS can be customized with different modules that are suitable for different contexts. This tutorial is helpful for new users and developers who would like to know the features of OpenMRS. Individuals who would like to evaluate and try to see if OpenMRS fits their healthcare needs will also benefit from this tutorial.
Data Science Deep Roots in Healthcare IndustryDinesh V
Data Science transforms the healthcare industry with impeccable solutions that can improve patient care through EHRs, medical imaging, drug discovery, predictive medicines and genetics and genomics.
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...Perficient, Inc.
The average academic research organization (ARO) and hospital has many systems that house patient-related information, such as patient records and genomic data. Combining data from a variety of sources in an ongoing manner can enable complex and meaningful querying, reporting and analysis for the purposes of improving patient safety and care, boosting operational efficiency, and supporting personalized medicine initiatives.
In this webinar, Perficient’s Mike Grossman, a director of clinical data warehousing and analytics, and Martin Sizemore, a healthcare strategist, discussed:
-How AROs and hospitals can benefit from a systematic approach to combining data from diverse systems and utilizing a suite of data extraction, reporting, and analytical tools, in order to support a wide variety of needs and requests
-Examples of proposed solutions to real-life challenges AROs and hospitals often encounter
Precision and Participatory Medicine - Medinfo 2015 Panel on big data. Includes the proposal to use the term Expotype to characterise the Exposome of an individual. Electronic expo typing would refer to the automatic construction of individual expo types from electronic clinical records and other sources of environmental risk factor and exposure data.
Improving health care outcomes with responsible data scienceWessel Kraaij
Keynote presentation by Wessel Kraaij at the Dutch pattern recognition and impage processing society (NVPBV) 29/5/2018, Eindhoven.
This talk discusses
1. trends in health care and respondible data science and their intersection
2. Secure federated analytics on distributed data repositories
3. Generating clinically relevant hypotheses from patient forum discussions.
> Definition of RWD
> RWD - Big Data Characteristics
> Sources of RWD
> Important Stakeholders
> Benefits of RWD
> Why Data Sharing is Important?
> Benefits of Data Sharing
> Who Benefits?
> Ultimate Goals
> Case Studies
> Challenges
> Data Privacy Scenario
> Data Security in India
> Regulatory Perspectives Around RWD
> How to Encourage Data Sharing?
The healthcare industry has quietly shed the laggards tag and has quickly emerged as frontrunners in digitization. Hospitals are driving technology advancements by creating a digital framework for seamless integration of all aspects of patient care and administration. There are 5 major themes that are seen as critical in the hospital IT ecosystem – Smart Care, Patient Information Management, Remote Care, Medical Devices, and Intelligent Enterprise Systems.
Large enterprises such as Microsoft and Accenture are collaborating with healthcare providers to address a variety of use cases such as chronic disease management, virtual care solutions, risk scoring, patient tracking and monitoring, precision medicine, and patient on/off-boarding. Accenture and Microsoft helped Spain’s Basque Country Health Centre build a remote elderly patient monitoring system. Athenahealth’s cloud-based network system helps Minnie Hamilton Health System identify bottlenecks and streamline the revenue cycle.
Download the report as we provide an overview of the hospital IT landscape, understand digital transformation trends across these 5 major themes and the opportunities available for vendors and service providers.
MIE Medical Informatics in Europe: European Federation for Medical Informatics (EFMI) annual meeting
Worklshop: Addressing Patient Adherence Issues by Engaging Enabling Technologies
Chair: Pei-Yun Sabrina Hsueh (IBM T.J. Watson Research Center)
Pei-Yun Sabrina HSUEHa, , Marion BALL b,a, Michael MARSCHOLLEKc, Fernando J. MARTIN-SANCHEZd , Chohreh PARTOVIANa, and Vimla PATELe
aIBM T.J. Watson Research Center, NY, USA
b John Hopkins University, MD, USA
c Hannover Medical School, Germany
d Melbourne Medical School, Australia
e Center for Cognitive Studies in Medicine and Public Health, The New York Academy, USA
Abstract One of the well known issues providers have contended with for many years is the issue of patients’ adherence to their care plans and medications outside clinical encounters. In this workshop, we review proof of concept studies using technology at the point of care to assess patient literacy and self-efficacy to provide timely intervention, remedy, and improvements in cost and quality. We focus on patient-generated information, including patient reported data and measurements from devices and sensors, as key to improving patient safety, gaining “meaningful use” data, improving patient centric care, and assisting providers in learning more about their patient needs to improve outcomes. We look into barriers to adherence, basic understanding of the patients and providers roles in improving adherence, and the use of technology to assist patients in staying on track. The participants will address their findings in the integration of patient-generated information into everyday life and clinical practice and share lessons learned from implementing these designs in practice. This workshop aims to share requirements for the next-generation healthcare systems, especially in areas where the explosive availability of patient-generated data is expected to make impacts.
Big Data Provides Opportunities, Challenges and a Better Future in Health and...Cirdan
This presentation was delivered by Ashraf Mina, NSW Pathology at the Pathology Horizons 2017 Conference in Cairns, Australia.
Pathology Horizons 2017 is an annual CPD conference organised by Cirdan on the future of pathology. You can access more information about the event at www.pathologyhorizons.com
The company was founded in 2010 and is headquartered in Lisburn, Northern Ireland and has additional offices in Canada and Australia.
Cirdan is also responsible for organising Pathology Horizons, an annual and open CPD conference on the future of pathology. For more information visit - www.pathologyhorizons.com
apidays LIVE India - The digitisation of healthcare by Dr S.S. Lal, Global Fo...apidays
apidays LIVE India 2021 - Connecting 1.3 billion digital innovators
May 20, 2021
The digitisation of healthcare
Dr S.S. Lal, President of Global Foundation for Health and Hygiene
Derick Mitchell_Biobanking from the patient perspective.pdfipposi
IPPOSI CEO Derick Mitchell presented the patient perspective on biobanking at the 2023 WECAN Academy for Cancer Patient Advocates on July 2nd, 2023 in Frankfurt, Germany.
Mental Health - Leading the data sharing charge with a rights-based approachipposi
Frankie Prendergast's (Digital Health Applications Programme Manager in St Patrick's Mental Health Services) presentation on health information at the 2023 IPPOSI Conference.
Muiris O'Connor, Assistant Secretary of the Department of Health, presented key government updates on health information at the 2023 IPPOSI Conference Building a Data Sharing Health Sector in Ireland.
Clinical Workflow for Capture of Patient Registry Dataipposi
Clare Harney, Managing Director of HD Health, gave a lightning presentation on managing data for patient registries at the 2023 IPPOSI Conference on Building a Data Sharing Health Sector in Ireland.
EU Clinical Trials Regulation - IPPOSI perspectiveipposi
IPPOSI CEO, Dr Derick Mitchell delivered a presentation on the EU Clinical Trials Regulation from the patients' perspective at the 20th International Conference on Pharmaceutical Medicine, Athens, Greece.
Patient Centricity in Value-based healthcare, Sept 2022ipposi
IPPOSI CEO Derick Mitchell delivered a presentation as part of the RCSI Value Based Healthcare Webinar on Patient Centricity on Sept 18th, 2022.
The Future of Value Based Healthcare in Ireland webinar series is run by The RCSI Healthcare Outcomes Research Centre, Janssen Sciences Ireland UC and Novartis Ireland.
2022 World Day Brain Event - IPPOSI Presentationipposi
Laura Kavanagh, Research and Advocacy Manager in IPPOSI, gave a presentation on World Brain Day 2022 at an event hosted by the Neurological Alliance of Ireland.
In October 2020, IPPOSI published a membership engagement survey on its draft 4-year strategy. This slide deck captures the summary results of the survey.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Connected Health & Me - Matic Meglic - Nov 24th 2014
1. Data sharing
and how it’s changing healthcare
Asst Prof Matic Meglic MD PhD MBA
Strategy Director, Medtronic Hospital Solutions EMEA
@CONNECTED HEALTH & ME
Dublin, Nov 24 2014
8. Key change drivers / enablers in healthcare
and their implications in healthcare:
• Affordable Technology
• Connected 24/7
• The quantified self
• Big Data & Open Data
• The empowered patient
• Personalized medicine
• New ePublicHealth paradigm
10. Empower to discover
• PatientsLikeMe
• Frost et al. JMIR 2011
• taking certain drugs “off-label“
with higher perceived efficacy
• side effect of amitriptyline (dry
mouth) as the purpose for taking
the drug (e.g. to treat excessive
salivation).
11. ePublicHealth paradigm change
• Personalisation of public health
• Infomediation (and consequent patient empowerment)
• Infodemiology, infoveillance
15. So the clash of the titans is not (just) about
data..
• Google Health Kit
• Apple Health Kit
• Microsoft Health & HealthVault
• Truckloads of new smart devices (wearables,
implantables, ‘dissolvables’, ‘invisibles’) – for lifestyle and
healthcare use.
• Analytics and prediction based on your health data:
– At physician’s office
– On your smartphone
20. Caution is however needed..
• Hacking attacks on remote devices
• Example of Melanoma Apps
• Access control breach
21. Health Data Landscape
• ‚Open‘ data (alltrials, care.data, number of pharma initiatives)
• Pharma 3.0 (E&Y report)
• US HIPAA/HITECH, Accountable Care, Meaningful Use
• mHealth (recent green paper by EC)
• EU Personal Data Protection Regulation proposal
• EU Cross-border Health care Directive (Art. 14)
• EU eHealth Network Guidelines & Multi-Annual Work Plan
• EU H2020 & AAL
• EU: eHN, eHGI, IHI, etc. epSOS, SHN, EXPAND, PARENT…
23. www.patientregistries.eu
PARENT Joint Action tackles the unclear EU
Registry Landscape
• Where are the patient registries?
• Can we access their data? (for Public Health, Research)
• Do we understand the data in the same way?
• Processes to exchange data?
• Then provide tools to answer these Qs.
24. www.patientregistries.eu
Two key use cases are supported.
Use case 1:
• Help existing and new registries to be more
interoperable (Guidelines, best practices, CDS, SW)
• Assess Interoperability of these registries/data
sources (Assessment Tool)
Use case 2:
• Ability to identify registries/data sources (PARENT
Registry of Registries)
• Provide search & retrieval and maintenance of (RoR)
metadata from these registries
• Support exchange of data across registries (Query
broker)
25. www.patientregistries.eu
Knowledge Management Platform
PARENT Framework
Guidelines,
Recommendations,
Methodologies
Services, SW
tools
repository
Best
practices
Registry of
Registries,
Assessment Tool
Common
information
model,
ontologies,
vocabularies
Delivering PARENT
26. www.patientregistries.eu
Scenarios and use of PARENT results
• ESC: switch from their own RoR to PARENT RoR
• Arthroplasty: EAR collecting data from registries for safety
analysis
• MoH Slovenia (2014): use RoR for assessment of RD registries
• Valdoltra hospital Slovenia (2015): National registry for
arthroplasty using PARENT Framework
• Contributing to (2015): Irish Epidermolysis Bullosa Registry
and International Severe Acute Eczema registry
28. www.patientregistries.eu
Future vision
• PARENT Guidelines and IOp assets
– Serve as a fundamental layer for secondary use of registry data: build
registries, search for data, retrieve data.
– Formally adopted by MS and EC initiatives (Safety, HTA, Post
marketing, etc.)
– Sustainable and further developed using a combination of biz models
(EC, MS, market)
• Patient focus (PROs, care&outcome benchmarking ->
future: patients request enrolment.
31. Hospital Solutions: Developing services and
solutions spanning the care continuum and
grounded in our therapies
• Predictive analytics
• Patient screening
• Patient diagnostics
Disease
Management
• Remote monitoring
• Patient follow-up
and support
• Track disease progression
• Patient outreach
• Patient education
• Patient referral
Patient
Identification
Patient
Action
Patient
Management
• Core Medtronic therapies &
clinical support
• Care pathway management
• Process excellence
/ lean sigma
• CathLab managed services
Therapy
Delivery
32. Question 2- How can technology support people as they age?
Cardiocom: over 80.000 patients served daily in US
COPD pilot in UK:
• 24% reduction in GP appointments
• 62% of patients having more confidence to self-
manage
their COPD trigger symptoms.
• 97% patient satisfaction rate
• 94% service compliance rate
Now looking to scale up to a system wide deployment in
order to deliver wider benefits.
34. Lessons learnt:
• HC change: build platforms to connect all
stakeholders
• HC sustainability: Patients are a very valuable
resource
• Provide smart incentives tied to performance and
outcome indicators
• Data, registries: it’s a long-distance race.
35. To build future-proof healthcare:
• Empower patients (access to own data & context
knowledge for decision making)
• Use data smartly (context)
• Change design of health care system (patient at
the centre, stepped, coordinated care; IT tools;
process thinking)
• Open data (but cautiously)
36. www.patientregistries.eu
EU registries in future:
• Central authorities:
– Registry methodology and reusable IT assets (e.g. CDE)
– RoR
– Audits&benchmarking
• Shared data use model with the industry that drives..
• Sustainable funding (combo of gov. & industry)
• Patient as stakeholder: PROs/PROMs; integration with
PHR (and of course EHR)
37. Thank you for your attention!
matic.meglic@medtronic.com
@matic_meglic